Core Viewpoint - The article discusses the 35th anniversary of the Pudong development and the 5th anniversary of its role as a leading area for socialist modernization, highlighting expert recommendations for future economic and social development in Pudong [1][5]. Group 1: High-Level Reform and Opening Up - Experts suggest that Pudong should focus on targeted reforms in market access, service trade, and overseas investment to convert institutional advantages into high-quality development and competitive advantages in international cooperation [4]. - The emphasis is on activating new momentum for high-quality development through high-level reform and opening up [4]. Group 2: Innovation and Economic Transformation - Recommendations include accelerating the establishment of a vibrant and open innovation ecosystem to achieve breakthroughs in high-level technological self-reliance and new productive forces [4][5]. - Pudong is encouraged to focus on strategic fields such as integrated circuits, life sciences, and artificial intelligence to overcome technological barriers and enhance basic research investment [5][6]. Group 3: Global Resource Allocation - Experts recommend that Pudong play a central role in the new development pattern and domestic-international dual circulation, leveraging its strengths in attracting and exporting resources [4]. Group 4: Urban Governance and Social Development - Suggestions include transitioning urban governance from merely addressing problems to building an institutional ecosystem, enhancing social governance, and innovating public services to promote common prosperity [4]. Group 5: Party Building and Leadership - The importance of strong party building as a means to ensure high-quality development is emphasized, with a call for Pudong to contribute significantly to the modernization of the socialist state and the realization of the Chinese Dream [4].

Group 1 - The Taizhou Venture Capital Conference was held on December 22, focusing on creating a new investment ecosystem and development blueprint with over 400 leaders and representatives from government, venture capital, and financial services [1] - Taizhou is characterized as a city thriving on private enterprises, entrepreneurship, and strong industries, aiming to transition from an advanced manufacturing base to a "smart manufacturing" hub [1] - The conference introduced the "Opinions on Promoting High-Quality Development of Venture Capital in Taizhou" and highlighted the unique advantages of the Binjiang Headquarters Innovation Port, along with future industry funds and acquisition mother funds [1] Group 2 - The conference released the 2025 list of China's new benchmark cities for venture capital, with Taizhou ranking among the top 10 alongside cities like Jiaxing and Kunming [2] - A total of 20 fund cooperation projects were signed, with a total scale of 171 billion yuan, and 32 key investment projects were signed, amounting to a total investment of 199 billion yuan, covering sectors such as semiconductors, optoelectronics, robotics, artificial intelligence, and synthetic biology [2] - Strategic cooperation agreements were signed between the Taizhou government and various organizations, including the China Investment Development Promotion Association and the China Resource Recycling Group [2]

Core Viewpoint - The discussion surrounding Hangzhou reflects a dichotomy between perceptions of population decline and the city's ongoing attractiveness, highlighting the need for cities to ensure that macroeconomic growth translates into tangible benefits for individuals [1][3][11] Population and Demographics - Hangzhou's resident population reached 12.624 million in 2024, an increase of 102,000 from the previous year, marking a decade of consistent population growth of over 100,000 annually, making it the leading city in the Yangtze River Delta for population increase [3] - During the 2025 Spring Festival travel season, the inter-regional movement of people in Hangzhou reached 142 million, a year-on-year increase of 7.2%, setting a historical record [3] - The influx of young, highly educated individuals is notable, with over 364,000, 390,000, and more than 400,000 university graduates under 35 being introduced annually over the past three years [3] Talent Attraction and Quality of Life - Hangzhou has risen to fourth place in the national ranking for attracting talent born after 1995, surpassing Guangzhou, according to a report by Zhilian Recruitment and Zeping Macro [5] - The city has been recognized as the "most livable city in China" for 19 consecutive years, the only city to receive this honor, indicating a strong reputation for quality of life [5] Structural Changes and Economic Transition - The narrative of population decline is largely driven by the challenges faced in the once-thriving live-streaming e-commerce sector, which has seen a rational adjustment and income fluctuations, leading to anxiety about job opportunities [3][8] - Hangzhou is undergoing a structural transformation in its economy, with the emergence of the "Six Little Dragons" and the establishment of the "296X" advanced manufacturing cluster, focusing on AI and robotics, among other sectors [8][9] Urban Development and Spatial Dynamics - The city is shifting from a single-center model around West Lake to a multi-center, networked urban structure, with new centers like Qianjiang New City and Future Technology City emerging, which has led to increased visitor numbers in surrounding areas [9][11] - This spatial transformation is seen as a positive development for urban capacity, although it has contributed to perceptions of population decline [11] Governance and Community Engagement - Hangzhou's approach to governance emphasizes understanding and addressing the specific needs of various community groups, as demonstrated by initiatives like the "Rider Code" to facilitate delivery for couriers and the installation of elevators in older residential buildings for the elderly [12][14] - The city's ability to translate the concept of being a "people's city" into actionable policies that enhance daily life is crucial for maintaining its status as a livable city [14][15] Conclusion - The ongoing discussions about youth retention and urban challenges should be viewed as an opportunity for cities to recalibrate their focus on enhancing individual experiences and addressing community needs, ultimately fostering a deeper connection between urban development and citizen satisfaction [15][16]

Core Viewpoint - During the "14th Five-Year Plan" period, China's bio-manufacturing industry has experienced significant growth, becoming a crucial force for optimizing and upgrading the economic structure, with a total scale reaching 1.1 trillion yuan [2][3]. Industry Overview - The bio-manufacturing industry in China has steadily expanded, achieving a total scale of 1.1 trillion yuan, with bio-fermentation products accounting for over 70% of global production [3][4]. - The annual output value of sub-sectors such as food additives and biopharmaceuticals exceeds 400 billion yuan, establishing bio-manufacturing as a new economic growth point [3][4]. Technological Innovation - China's bio-manufacturing sector holds over 20% of global patent applications, with the establishment of several national key laboratories and industrial innovation platforms [4]. - New instruments such as domestic high-throughput gene sequencers and large-scale fermentation tanks have been successfully industrialized [4]. Industrial Cluster Development - Regions like Beijing and Tianjin have emerged as innovation hubs for bio-manufacturing, while provinces such as Shandong, Heilongjiang, and Henan have developed into major manufacturing bases for bulk bio-fermentation products [5]. - The "14th Five-Year Plan" has fostered the growth of numerous backbone enterprises with annual revenues exceeding 10 billion yuan, along with the emergence of several national-level manufacturing champions and specialized "little giant" enterprises [5]. Policy and Recognition - The Ministry of Industry and Information Technology (MIIT) has released a list of 35 landmark bio-manufacturing products, with companies like New Hope Liuhe, Blue Crystal Microbiology, and Huaxi Biological among the applicants [6][8].

Group 1 - The core viewpoint of the report is that by the end of 2024, China will have a total of 816 potential unicorn companies, with 255 new entrants, indicating a significant growth in the number of such companies, driven by cutting-edge technology and capital talent aggregation [1][2] - The number of potential unicorn companies in China has increased from 296 to 816 over the past six years, representing a growth of approximately 1.8 times, with over 200 new companies added each year, resulting in a substantial pool of high-quality tech innovation companies [1] - Over 90% of potential unicorn companies are in the frontier technology sector, with nearly 70% holding authorized invention patents, totaling 13,000 patents, and an average of 6 PCT applications per company [1] Group 2 - In 2024, 50% of potential unicorn companies (409 companies) are expected to secure new financing, totaling nearly $13 billion, which is an 18.7% year-on-year increase [2] - More than 60% of companies in sectors such as chips, new semiconductors, robotics, new energy vehicles, new materials, and commercial aerospace have received new financing [2] - Over 80% of potential unicorn companies have received investment from state-owned investment institutions, highlighting the significant role of state capital in the investment landscape [2]

Core Insights - Synthetic biology company "YouTian Bio" recently secured several million yuan in angel round financing, led by Changzhou Qihang Synthetic Biology Venture Capital Fund, to focus on the large-scale production of somatostatin, expand its synthetic biology product pipeline, and iterate its technology platform [1] Company Overview - YouTian Bio was established in 2023 by founder and chairman Cui Junsheng, a serial entrepreneur with a background in biology from Nankai University, who has previously participated in significant national drug development projects [1] - The company aims to initiate a "sweetness revolution" from carbohydrates to proteins by leveraging new technologies in collaboration with professors from institutions like the Chinese Academy of Sciences and Tsinghua University [1] Product Development - YouTian Bio has overcome the challenges of developing and mass-producing the natural sweet protein "somatostatin" through synthetic biology technology, establishing a large-scale fermentation system in Changzhou [1][3] - Somatostatin is a natural high-intensity sweet protein with a sweetness level up to 3000 times that of sucrose, offering advantages such as no aftertaste and being digested into amino acids without causing blood sugar spikes [3] Market Potential - The demand for low-sugar, low-calorie health foods is increasing globally, driving the growth of the natural food additive market, particularly for protein sweeteners [6] - YouTian Bio's innovative approach aims to address the limitations of existing sweeteners, which include high costs and health risks associated with consumption [2][3] Technology Platform - The company has developed the Bio-Sup™ technology platform, which integrates research and development, pilot testing, and mass production, ensuring a complete technological chain [4][5] - This platform includes a rich library of chassis strains and functional components, enabling efficient design and integration of metabolic pathways to ensure high yield potential [5] Production Capacity - YouTian Bio's production base is located in the Changzhou Liyang High-tech Zone, where it is building a standardized and large-scale fermentation production system, having completed industrial trial production and is advancing a 30-ton fermentation scale production line [5][6] - The recent investment will further enhance production capacity and strengthen the research and development team, facilitating collaboration with upstream and downstream companies in the food and beverage industry [6]

Core Viewpoint - The article discusses the recent angel round financing of "YouTian Biotechnology," which aims to scale up the production of the natural sweet protein "Soma Sweet" using synthetic biology technology, addressing the challenges of high costs and limited supply in the natural sweetener market [1][9]. Company Overview - YouTian Biotechnology was established in 2023 by Chui Junsheng, a serial entrepreneur with a background in biology from Nankai University. The company focuses on synthetic biology and aims to revolutionize the sweetener industry by developing Soma Sweet through microbial fermentation [1][9]. Product Development - Soma Sweet, a natural high-intensity sweet protein discovered in the West African yam fruit, is 3000 times sweeter than sucrose and has no aftertaste, making it suitable for various food applications [5][6]. - The company has developed a Bio-Sup™ technology platform that integrates gene analysis, AI protein structure optimization, and process development, allowing for the creation of multiple product lines, including Soma Sweet and various enzymes [1][12]. Market Potential - The demand for low-sugar and low-calorie food products is increasing globally, and the market for natural protein sweeteners is expected to grow significantly. YouTian Biotechnology aims to meet this demand by expanding its product line and collaborating with food and beverage companies [13]. Production Capabilities - The production facility is located in the Changzhou Liyang High-tech Zone, where a standardized and scalable fermentation production system is being established. The company has completed industrial-scale pilot production and is working on a production line with a capacity of 30 tons [13]. - The use of synthetic biology for the production of Soma Sweet allows for stable supply and cost reduction, addressing the previous challenges of low availability and high prices associated with natural extraction methods [9][12]. Investment and Future Plans - The recent funding from Changzhou Qihang Synthetic Biology Venture Capital Fund will be used to enhance production capacity, strengthen the research team, and accelerate market penetration of Soma Sweet [13].

百亿市场创业窗口正在关闭 出品 | 虎嗅科技医疗组 作者 | 陈广晶 编辑 | 苗正卿 头图 | 视觉中国 让赵亚冉感慨万千的一幕发生在3年前（ 2022年 ），那正是美元基金大退潮的时候。处于商业化关键阶段 的未名拾光，急需资金来建设工厂。恰逢疫情期间，赵亚冉每天收拾停当，简单吃完早饭，就坐在电脑前 等待约好的投资人做线上交流。路演的那一个月里平均每天要见三到四个投资人。一共见了六七十家机构 的投资人。"业内的投资人几乎都见了个遍。" 好不容易敲定投资，就在11月份要交割的时候，跟投机构又忽然改主意了。"一下子出现2000多万元的缺 口，当时我脑袋嗡的一下。"赵亚冉告诉虎嗅，他最担心的是跟投基金撤退，会导致领投撤资。 那时候还在疫情期间，未名拾光账上的钱仅能维持基础运营一年，如果融不到这笔钱，建厂计划泡汤，订 单无法按期交付，公司基本上会处于慢性死亡的状态。 很多企业没有未名拾光这么幸运。2022年以来，有多家合成生物知名企业破产或陷入危机，包括号称合成 生物鼻祖的Amyris。 在冷暖交替的巨变和命运的跌宕起伏中，未名拾光和它所身处的合成生物正在AI等新技术浪潮裹挟中，涌 入一个拥有无限可能又容错率极低的 ...

本届大赛赛题设计仍为"技术赛"与"案例赛"相结合的形式，围绕"安全治理"和"创新发展"两大方向设置赛题，吸引了全 国顶尖团队和技术精英参与。酶赛生物报送的案例《人工智能赋能新型酶催化非天然手性氨基化合物合成》从一众高水平 项目中脱颖而出，取得佳绩。 第六届中国人工智能大赛由国家互联网信息办公室、公安部指导，厦门市人民政府主办，旨在进一步推动人工智能技术创 新发展，促进人工智能与实体经济深度融合，加快构建以大模型为代表的人工智能技术应用落地。 【SynBioCon】 获 悉， 12 月 12 日，第六届中国人工智能大赛颁奖典礼在厦门圆满收官。酶赛生物携 AI 驱动的合成 生物制造创新方案 ，从全国强队中突围，斩获人工智能赋能合成生物制造创新案例赛 A 级荣誉，同时获奖的还有中科院 天工所孙周通团队等，再次验证我们在人工智能与产业融合赛道的硬核实力。 Bio-based 2026 第十一届生物基大会暨展览 The 11th Bio-based Industry Conference & Exhibition 跨越新周期 澎湃新生机 7 场行业评选 新叶奖(第四届) 11 场论坛+7 大同期活动 关键词 | 底层技 ...

Core Viewpoint - The article highlights the rapid growth and innovation in the synthetic biology industry in Wuqing, Tianjin, particularly through the success of Tianjin Xiaowei Biotechnology Co., Ltd., which focuses on the development and production of probiotics, showcasing a shift towards domestic production and technological advancement in the sector [2][3][5]. Company Summary - Tianjin Xiaowei Biotechnology Co., Ltd. has grown into a leading enterprise in the probiotic industry, with over 10,000 strains collected and preserved, and 52 mature production strains [3]. - The company has developed 21 invention patents and collaborates with multiple research institutions, contributing to the development and production transformation of over 20 strains [3]. - The expected annual output value for the company is projected to exceed 50 million yuan, with plans for further capacity expansion in Wuqing [3]. Industry Summary - Wuqing has established a synthetic biology industry ecosystem that includes gene sequencing, gene synthesis, strain screening, and industrial fermentation, supported by leading projects such as the Tianjin University Synthetic Biology Frontier Research Institute [5][6]. - The research institute has successfully created a synthetic pathway for rose alcohol in yeast, marking a significant advancement in green and sustainable biomanufacturing [5]. - The region is home to 300 biopharmaceutical companies, with 56 of them being above-scale enterprises, and has achieved an industrial output value of 4.336 billion yuan from January to October 2025 [8]. - The Wuqing district aims to develop a trillion-level biopharmaceutical industry cluster, integrating biopharmaceuticals, medical devices, precision medicine, and synthetic biology manufacturing [8].